rdf:type |
|
lifeskim:mentions |
|
pubmed:dateCreated |
2009-4-22
|
pubmed:abstractText |
Cholera remains a serious public health problem in low-income countries despite efforts in the past to promote oral rehydration therapy as major treatment. In 2007, the majority of worldwide cases (94%) and deaths (99%) were reported from Africa. To improve cholera control efforts in addition to maintaining and improving existing water supply, sanitation and hygiene behaviour measures, the World Health Organization has recently started to consider the use of vaccines as an additional public health tool. To assess this new approach in endemic settings, a project was launched in Zanzibar to vaccinate 50,000 individuals living in communities at high risk of cholera with an oral two-dose vaccine (Dukoral). Immunisation programmes in low-income countries have suffered a reduced coverage or were even brought to a halt because of an ignorance of local realities. To ensure the success of vaccination campaigns, implementers have to consider community-held perceptions and behaviours regarding the infectious disease and the vaccine of interest. The main aim of this study is to provide advice to the Ministry of Health and Social Welfare of Zanzibar regarding routine introduction of an oral cholera vaccine from a socioeconomic and behavioural perspective as part of a long-term development for a sustained cholera prevention strategy.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-10574240,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-11164965,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-12113453,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-12615424,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-14738797,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-15186348,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-15473518,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-15473519,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-15609781,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-15609782,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-15609785,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-15728808,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-16085859,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-16137802,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-16159688,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-16765498,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-16914700,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-17207145,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-17388657,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-17584531,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-1787275,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-17978075,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-17985828,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-18044983,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-18544214,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-18668979,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-3062796,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-7502096,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-7502097,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-7967990,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-8852414,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19351401-8888470
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1471-2458
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
99
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19351401-Administration, Oral,
pubmed-meshheading:19351401-Adolescent,
pubmed-meshheading:19351401-Adult,
pubmed-meshheading:19351401-Attitude to Health,
pubmed-meshheading:19351401-Cholera,
pubmed-meshheading:19351401-Cholera Vaccines,
pubmed-meshheading:19351401-Cross-Sectional Studies,
pubmed-meshheading:19351401-Female,
pubmed-meshheading:19351401-Focus Groups,
pubmed-meshheading:19351401-Health Services Needs and Demand,
pubmed-meshheading:19351401-Health Services Research,
pubmed-meshheading:19351401-Humans,
pubmed-meshheading:19351401-Interviews as Topic,
pubmed-meshheading:19351401-Male,
pubmed-meshheading:19351401-Middle Aged,
pubmed-meshheading:19351401-Socioeconomic Factors,
pubmed-meshheading:19351401-Tanzania,
pubmed-meshheading:19351401-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance.
|
pubmed:affiliation |
Department of Public Health and Epidemiology, Swiss Tropical Institute, PO Box, Socinstrasse 57, 4002 Basel, Switzerland. christian.schaetti@unibas.ch
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|